Sign In
Buy BIIB
$207.94
+1.66 (+0.80%)
At Close: Aug 07, 2026
There are three reasons health care is the market's best sector today. These eight stocks are the most worry-free.
02:22pm, Saturday, 06'th Aug 2022 MarketWatch
Health-care stocks have both growth and defensive characteristics.
7 Cheap Blue-Chip Stocks to Buy Before They Rebound
08:00am, Friday, 05'th Aug 2022
Trying to find a good bargain seems tough these days, but there are certainly opportunities for savvy investors. Looking for cheap blue-chip stocks to buy before they rebound is a smart strategy right
Is VanEck Morningstar Wide Moat ETF (MOAT) a Strong ETF Right Now?
10:20am, Thursday, 04'th Aug 2022 Zacks Investment Research
Smart Beta ETF report for MOAT
Should VanEck Morningstar Wide Moat ETF (MOAT) Be on Your Investing Radar?
10:20am, Wednesday, 03'rd Aug 2022 Zacks Investment Research
Style Box ETF report for MOAT
These eight health-care stocks can keep you invested in the market with less worry
10:52am, Tuesday, 02'nd Aug 2022
You're tempted to increase exposure to stocks because of the market's strength. But you're still gun shy because of the painful selloff.
Good News for Retirees: Lower Medicare Part B Premiums Could Be Coming
09:55am, Sunday, 31'st Jul 2022 The Motley Fool
Bad news for Biogen could translate to lower Medicare Part B premiums for seniors.
AbbVie's (ABBV) Q2 Earnings Beat Estimates, Revenues Lag
07:40pm, Friday, 29'th Jul 2022 Zacks Investment Research
AbbVie's earnings (ABBV) beat estimates for second-quarter 2022, while sales miss the same. ABBV's immunology and neuroscience drugs drive sales. Shares decline in pre-market trading.
Biotech Stock Roundup: BMY, BIIB's Q2 Earnings, GILD's Updates & More
03:15pm, Wednesday, 27'th Jul 2022 Zacks Investment Research
Earnings updates from Bristol Myers (BMY) and Biogen (BIIB) are a few key highlights from the biotech sector during the past week.
Drug, Biotech Stocks' Q2 Earnings on Jul 27: BMY, GSK & More
03:04pm, Tuesday, 26'th Jul 2022 Zacks Investment Research
Let's look what is in store for the four drug, biotech companies slated to release quarterly results tomorrow- BMY, GSK, ALKS, TEVA
Drug, Biotech Stocks' Q2 Earnings on Jul 27: BMY, GSK & More
12:25pm, Tuesday, 26'th Jul 2022
Let's look what is in store for the four drug, biotech companies slated to release quarterly results tomorrow- BMY, GSK, ALKS, TEVA
FDA Accepts Biogen’s New Drug Application and Grants Priority Review of Tofersen for a Rare, Genetic Form of ALS
11:30am, Tuesday, 26'th Jul 2022 GlobeNewswire Inc.
CAMBRIDGE, Mass., July 26, 2022 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced that the U.S. Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) for tofersen
FDA grants Priority Review to Biogen's ALS therapy
10:21am, Tuesday, 26'th Jul 2022
Biogen Inc. BIIB, +1.34% said Tuesdsay that its experimental treatment for a type of amyotrophic lateral sclerosis (ALS), which is often referred to as Lou Gehrig's disease, has been granted Priority
Is Invesco Dynamic Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?
10:20am, Tuesday, 26'th Jul 2022 Zacks Investment Research
Smart Beta ETF report for PBE
Biogen Inc. (BIIB) Upgraded to Buy: What Does It Mean for the Stock?
04:00pm, Monday, 25'th Jul 2022 Zacks Investment Research
Biogen Inc. (BIIB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
BIIB vs. ILMN: Which Stock Should Value Investors Buy Now?
03:40pm, Monday, 25'th Jul 2022 Zacks Investment Research
BIIB vs. ILMN: Which Stock Is the Better Value Option?
